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Linear IgG deposits along the basement membrane of 
adnexa has been proposed to be useful in the diagno-
sis of bullous pemphigoid (BP), but no controlled stu-
dies have been performed. This study evaluated linear 
IgG fluorescence of the basement membrane of sweat 
gland ducts (SGD) and other adnexa in perilesional 
biopsies from patients with BP (n = 64) and controls 
(n = 82), using direct immunofluorescence microscopy. 
Fluorescence intensity was graded semi-quantitatively. 
Positive SGDs were found in 58 (90.6%) patients with 
BP and 44 (53.7%) controls, a statistically significant 
difference (p < 0.0001). The sensitivity of positive 
SGDs for BP was high (90.6%), but the specificity was 
low (46.3%). Only strong fluorescence intensity was 
associated with high specificity. In conclusion, positive 
SGDs in direct immunofluorescence microscopy are 
highly sensitive for BP; however, only strong fluorescen-
ce has acceptable specificity. Weak positivity of SGDs 
without linear fluorescence of the epidermal basement 
membrane may not be sufficiently specific for BP.
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Bullous pemphigoid (BP) is the most common auto­immune blistering disease of the skin. Diagnosis of 
BP relies on histopathological examination, including 
direct immunofluorescence microscopy (DIF) on peri­
lesional skin biopsy specimens, in addition to detection 
of circulating autoantibodies by indirect immunofluo­
rescence microscopy and enzyme-linked immunoassays 
(ELISAs) (1, 2).
DIF is a specific, and the most sensitive, diagnostic 
test for BP (3, 4). It reveals linear IgG and/or comple­
ment C3 deposition at the dermal–epidermal junction. 
Besides the classical examination of the epidermal 
basement membrane (BM), recent reports have shown 
that the immunofluorescence of the BM of sweat glands 
and hair follicles might have a diagnostic relevance in 
autoimmune blistering diseases (5, 6).
However, previous studies have not analysed the ope­
rating characteristics of adnexal fluorescence. 
The objectives of this study were to evaluate the im­
munofluorescence pattern and intensity of the sweat 
gland ducts (SGD) and other adnexal structures in BP 
and to compare them with a control group in order to 
assess their diagnostic performance. 
MATERIALS AND METHODS
Patients
A single-centre, case-control study was conducted on biopsy 
samples from 64 BP and 82 control patients at the Department of 
Dermatology and Allergology, Ludwig-Maximilian University, 
Munich, Germany. This type of non-interventional study on labo­
ratory samples that were produced for routine diagnostic purposes 
does not require ethical approval in Germany.
Archived frozen cutaneous biopsy specimens of 51 patients with 
BP who had been diagnosed in 2015 were re-cut and re-stained; in 
addition, 13 further patients who were diagnosed during the course 
of the study (January–April 2016) were included in the BP group. 
The diagnosis was based on the integration of clinical, histological, 
immunopathological and serological findings. Inclusion criteria 
were a clearly visible, continuous, linear IgG fluorescence along 
the epidermal basement membrane, the presence of SGDs in the 
sections, and the evident diagnosis of BP (4). Control DIF sections 
were obtained from 82 patients with various other skin disorders 
diagnosed in 2016, in which BP could be clearly ruled out. Patients 
lacking a definite diagnosis or SGDs in the sections were excluded.
Immunofluorescence studies
The in vivo bound IgG autoantibodies were detected by DIF 
in the patients’ skin. All sections were stained with fluorescein 
isothiocyanate (FITC)-labelled goat anti-human IgG (#F1641, 
Sigma-Aldrich, St Louis, MO, USA) diluted 1:30 in phosphate-
buffered saline (PBS) for 30 min at room temperature in a dark, 
humid chamber. No blocking was used. Each section was exami­
ned by the first author for the fluorescence pattern and intensity 
of IgG in the epidermis, SGDs, hair follicles, and sebaceous 
glands, and then reviewed by the last author. SGDs in papillary, 
mid and deep dermis were assessed separately. The intensity of 
the fluorescence was semi-quantitatively graded between 0 and 4 
(0, no fluorescence; 4, strongest fluorescence). Examples of each 
intensity grade are shown in Fig. 1.
Some skin sections from patients with BP were selected ran­
domly and stained with anti-BP180 and anti-BP230 monoclonal 
antibodies (HD18 described elsewhere (7) and Cosmo Bio, CAC-
NU-01-BP1, respectively) to demonstrate the presence of BP180 
and BP230 proteins in the adnexal BM. The monoclonal antibodies 
were diluted 1:1 and 1:10 in PBS, respectively, and incubated for 
60 min at room temperature on the sections. After washing, bound 
antibodies were detected by FITC-labelled polyclonal antibodies 
directed against mouse IgG (#sc-3699 Santa Cruz Biotechnology, 
Dallas, TX, USA). 
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Statistical analysis
For comparison of intensities, Mann–Whitney’s non-parametric, 
unpaired, 2-tailed test was performed. GraphPad Prism version 
4.03 for Windows (GraphPad Software, San Diego, CA, USA) 
was used for calculations.
RESULTS
Sections from 64 patients with BP (30 females, 34 
males; mean age 78, range 8–96 years) were examined 
and compared with 82 control patients (43 females, 39 
males, mean age 63, range 18–90 years). Linear IgG 
fluorescence along the BM of SGDs and other adnexa 
was assessed in both groups. As an example positive, 
negative and false positive immunofluorescence of SGDs 
are shown in Fig. 2.
Detection of BP180 and BP230
Sections stained with anti-BP180 and anti-BP230 mo­
noclonal antibodies showed linear fluorescence along 
the BM of the epidermis, SGDs, sweat glands and hair 
follicles. As an example BP180 and 230 immunofluo­
rescence of SGDs and sweat glands are shown in Fig. 3.
Immunofluorescence of sweat gland ducts 
In the whole dermis. As mentioned above, all BP samp­
les showed linear IgG fluorescence along the epidermal 
BM, whereas control skin samples did not. SGDs were 
observed as round, oval or tubular structures in all layers 
of dermis. They were lined by 2 layers of monomorphic 
cuboidal cells, surrounding a narrow lumen. In contrast, 
sweat glands occurred only in the deep dermis, were 
composed of a single cell layer around a wider lumen 
and were differentiated from the ducts by the lipofuscin 
granules inside the lumina (Fig. 4). 
Fifty-eight (90.6%) patients with BP and 44 (53.7%) 
controls showed linear deposition of IgG along the BM 
of the SGDs. Fluorescence intensity of SGDs in DIF was 
significantly higher in patients with BP than in controls 
(p < 0.0001) (Fig. 5A). The sensitivity and specificity of 
positive SGDs for BP was 90.6% and 46.3%, respecti­
vely. With increasing intensity of the fluorescence, the 
sensitivity decreased, whereas the specificity increased. 
Positive SGDs with intensity grades 3 and 4 showed the 
lowest sensitivity (31.2%) and the highest specificity 
(97.5%) (Fig. 6). Fluorescence intensity of SGDs did 
not correlate significantly with the patients’ circulating 
BP180 and BP230 autoantibody titres.
In the papillary dermis. Within the papillary dermis, 
34 (53.1%) patients with BP and 51 (62.2%) controls 
had SGDs. Among patients with BP, 5 (14.7%) showed 
no fluorescence of the ductal BM, whereas 29 (85.3%) 
specimens showed linear fluorescence with intensity 
grades 1, 2 and 3 in 22 (64.7%), 6 (17.6%), and 1 (2.9%) 
cases, respectively. Among control subjects, 39 (76.5%) 
showed no fluorescence in the ductal BM, whereas 12 
(23.5%) specimens showed linear fluorescence with 
intensity grades 1 and 2 in 11 (21.5%) and 1 (2%) cases, 
respectively. The fluorescence intensities of SGDs in 
papillary dermis were significantly different between 
patients with BP and controls (p < 0.0001) (Fig. 5B). 
Fig. 1. Semi-quantitative grading of the fluorescence intensity of the sweat gland ducts (SGDs). (A) Intensity 0 SGD without fluorescence of the 
basement membrane (BM) (arrow). (B) Linear staining along the BM of intensity 1 (arrow) and 2 (arrow head) SGDs. (C) More prominent fluorescence 
of the BM of intensity 3 SGDs (arrow) next to the sweat glands (asterisk). (D) Strongest fluorescence of the BM of intensity 4 SGD (arrow).
Fig. 2. Assessment of linear IgG 
fluorescence along the basement 
membrane of sweat gland ducts 
(SGDs) in bullous pemphigoid (BP) 
and control sections. (A) Negative 
SGDs (arrows) in a control section. 
(B) Positive SGD (arrows) with strong 
fluorescence in a BP section. (C) 
False–positive SGD (arrow) with weak 
fluorescence in a control section.
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Positive SGDs in the papillary dermis with any intensity 
of fluorescence showed the highest sensitivity (89.2%) 
and those with intensities 3 and 4 the highest specificity 
(100%) to detect BP (Fig. 6).
In the mid-dermis. Within the mid-dermis, 48 (75%) 
patients with BP and 57 (69.5%) controls had SGDs. 
Eight (16.7%) BP specimens displayed no fluorescence, 
whereas 40 (83.3%) patients showed linear fluorescence 
of the ductal BM with intensity grades 1, 2, 3 and 4 in 
27 (56.3%), 7 (14.6%), 3 (6.2%), and 3 (6.2%) cases, 
respectively. Among control subjects, 43 (75.4%) pa­
tients displayed no fluorescence, whereas 14 (24.6%) 
specimens showed linear fluorescence of the ductal BM 
with intensity grades 1, 2, 3 in 9 (15.8%), 4 (7%) and 1 
(1.8) cases, respectively. The fluorescence intensities of 
SGDs in mid-dermis were significantly different between 
patients with BP and controls (p < 0.0001) (Fig. 5C). The 
sensitivity and specificity of the positive SGDs in mid-
dermis with any intensity of fluorescence were 83.3% and 
75.9%, respectively. SGDs with intensities 3 and 4 had 
98.3% specificity in mid-dermis; however, the sensitivity 
was 12.5% (Fig. 6).
In the deep dermis. Within the deep dermis, 47 (73.4%) 
patients with BP and 65 (79.2%) controls had SGDs. 
Among patients with BP, 8 (17%) showed no fluorescen­
ce, whereas 39 (83%) patients showed linear fluorescence 
of the ductal BM with intensity grades 1, 2, 3 and 4 in 
10 (21.3%), 12 (25.5%), 13 (27.7%) and 4 (8.5%) cases, 
respectively. Among control subjects, 29 (44.6%) showed 
no fluorescence, whereas 36 (55.4%) patients showed 
positive fluorescence with intensity grades 1, 2 and 3 in 
25 (38.5%), 10 (15.4%) and 1 (1.5%) cases, respectively. 
The fluorescence intensities of SGDs in the deep dermis 
were significantly different between patients with BP 
and controls (p < 0.0001) (Fig. 5D). Positive SGDs in 
the deep dermis with any intensity of fluorescence had 
83% sensitivity. The specificity was lower (43.9%) than 
SGDs in other levels of the dermis, but it increased with 
stronger fluorescence and SGDs with intensities 3 and 4 
showed 98.5% specificity to detect BP (Fig. 6).
Fig. 4. Differentiation of sweat gland ducts (SGDs) and sweat 
glands. (A) Appearance of SGDs (asterisks) and sweat glands (arrows) 
in haematoxylin-eosin- stained sections. (B) SGDs appear as round or 
oval structures lined by monomorphous keratinocytes around a narrow 
lumen in direct immunofluorescence (DIF) (asterisks). Sweat glands are 
differentiated from the SGDs by the lipofuscin granules, which are seen as 
orange-colored bright spots inside their lumina (arrows).
Fig. 3. Anti-BP180 and anti-BP230 staining of bullous pemphigoid 
sections. Linear staining along the basement membrane of sweat gland 
ducts (asterisk) and sweat glands (arrows) with (A) anti-BP180 and (B) 
anti-BP230.
Fig. 5. Comparison of the fluorescence intensity of sweat gland ducts 
(SGDs) between bullous pemphigoid (BP) and control patients. 
(A) The fluorescence intensity of the basement membrane (BM) of SGDs 
was significantly higher in BP patients compared with the controls in the 
whole dermis, (B) papillary dermis, (C) mid-dermis, (D) and deep dermis. 
BP patients also had a significantly higher fluorescence along the BM of 
(E) hair follicles and (F) sebaceous glands comparing to the controls. 
***Significant difference, p < 0.001.
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Immunofluorescence of hair follicles
Twenty (31.2%) BP samples contained hair follicles in 
the sections with intensity grades 0, 1, 2, 3 and 4 in 5 
(25%), 4 (20%), 8 (40%), 1 (5%) and 2 (10%) cases, 
respectively. On the other hand, 33 (40.2%) controls 
had hair follicles with intensity grades 0, 1, and 2 in 29 
(87.9%), 3 (9.1%) and 1 (3%) cases, respectively. The 
fluorescence intensities of hair follicles were signifi­
cantly different between patients with BP and controls 
(p < 0.0001) (Fig. 5E). The sensitivity and specifi­
city of the positive hair follicles with any intensity of 
fluorescence were 75% and 87.9%, respectively. The 
sensitivity decreased in hair follicles with intensities 3 
and 4 (15%), but they showed the highest specificity 
(100%) (Fig. 6).
Immunofluorescence of sebaceous glands
Fourteen (21.8%) patients with BP had sebaceous glands 
in the sections with intensity grades 0, 1, 2, 3 and 4 in 2 
(14.3%), 7 (50%), 3 (21.4%), 1 (7.1%) and 1 (7.1%) cases, 
respectively. On the other hand, 19 (23.2%) controls had 
sebaceous glands with intensity grades 0, 1, 2, and 3 in 13 
(68.4%), 4 (21.1%), 1 (5.3%) and 1 (5.3%) cases, respec­
tively. The fluorescence intensities of sebaceous glands 
were significantly different between patients with BP and 
controls (p = 0.0045) (Fig. 5F). Positive sebaceous glands 
with any intensity of fluorescence had 85.7% sensitivity 
and 68.4% specificity. The specificity reached 94.7% in 
sebaceous glands with intensities 3 and 4 (Fig. 6).
DISCUSSION
A few reports have already demonstrated the immuno­
reactivity of hair follicles, sweat glands and ducts in 
dermatitis herpetiformis (8), pemphigus, and BP (9, 10). 
In addition, recent studies have indicated that the im­
munofluorescence of SGDs and other adnexal structures 
might have a diagnostic importance in autoimmune bul­
lous diseases. For instance, Lehman & Camilleri (5) re­
ported that folliculosebaceous units and sweat apparatus 
(sweat glands and ducts) show high sensitivity in various 
immunobullous disorders. Lehman et al. suggested that 
the immunofluorescence pattern of adnexal structures 
might have a diagnostic value in the absence of inter­
pretable findings in the epidermis or dermal–epidermal 
junction. Similarly, a recently published study by Zhou 
et al. (6) reported that sensitivity of immunofluorescence 
of eccrine apparatus (eccrine sweat glands and ducts) is 
similar to that of the epidermis and hair follicles in both 
pemphigus vulgaris and BP. However, to our knowledge, 
no studies have been performed regarding the operating 
characteristics of SGD fluorescence in autoimmune 
blistering diseases, and no samples from control patients 
were examined in previous studies.
In our study, BM positivity of SGDs was significantly 
more common in each level of dermis in BP compared 
with the controls, especially within the mid and deep 
dermis. In addition, BM of hair follicles and sebaceous 
glands were more commonly positive in patients with 
BP than controls. These findings support the results of 
previous studies (5, 6). 
Unlike previous studies, we also examined the fluo­
rescence intensities and the localization of SGDs. IgG 
fluorescence of the BM of SGDs in each level of dermis, 
hair follicles, and sebaceous glands were significantly 
different between patients with BP and controls. IgG 
deposits along the BM of SGDs in the papillary dermis 
showed higher sensitivity compared with those in the mid 
and deep dermis. Although positive SGDs in papillary 
dermis showed a higher specificity than those in other 
levels of dermis, only fluorescence of strong intensity 
could reach an acceptable specificity. As false-positive 
SGDs, hair follicles, and sebaceous glands occurred 
commonly in control patients, but the intensity of false-
positive signal was relatively low, we can conclude that 
linear BM fluorescence of solely the adnexal BM is 
relevant only if the intensity of the fluorescence reaches 
at least grade 3.
We observed that DIF evaluation of SGDs is more 
useful than that of sweat glands, since sweat glands fre­
quently display positive fluorescence of strong intensity 
in most of the sections regardless of the diagnosis. We 
re-stained 5 randomly selected sections with a different 
secondary antibody, FITC-labelled rabbit anti-human 
IgG antibody (γ chain) (Dako-Biozol, Eching, Germany), 
in order to assess whether the distinct fluorescence pat­
Fig. 6. Sensitivity (A) and specificity (B) of sweat gland duct staining 
intensity in dermis (whole, papillary, mid- and deep dermis), hair 
follicles and sebaceous glands for diagnosis of bullous pemphigoid 
(BP) (64 BP and 82 control patients).
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terns of sweat glands were related to the reagent we used 
in the study, but found no difference between the 2 dif­
ferent antibodies. A recent report supported our observa­
tion, demonstrating the non-specific autofluorescence of 
haematoxylin-eosin stained eccrine sweat glands under 
the fluorescence microscope. Autofluorescence of SGDs 
was not observed (11). Thus, neither the presence of 
positive sweat glands, nor their intensity of fluorescence 
has a diagnostic value for BP. Therefore, evaluation of 
the SGDs with their localization and fluorescence inten­
sity is recommended for the diagnosis of BP instead of 
evaluation of the whole sweat gland apparatus (sweat 
glands and ducts).
Although IgG deposits in the BM of SGDs show a 
high sensitivity for BP, there is no evidence to suggest 
that either sweat glands, ducts or sweat are involved in 
the pathogenesis of BP. Dai et al. (12) reported a strong 
in situ expression of IL-31 in the SGDs and a weaker ex­
pression in the sweat glands in normal skin. Furthermore, 
it has been demonstrated that eccrine sweat contains IL-
1α, IL-1β, IL-8, and IL-31, and these proinflammatory 
cytokines are involved in the activation of epidermal 
keratinocytes (12, 13) indicating that sweat apparatus 
is not only important in thermoregulation but also has a 
role in cutaneous inflammation. 
Although the aetiology remains unknown, BP has been 
reported to be induced by some drugs, virus infections 
or physical factors (14). Excretion of drugs into ec­
crine sweat is a known phenomenon, which may result 
in several drug-related eccrine disorders (15). Eccrine 
acrosyringium has been shown to express class II major 
histocompatibility complex antigens which may play an 
immunological role against external agents (16). There­
fore, an immunological interaction between the drugs and 
sweat apparatus is possible. We demonstrated that BP180 
and BP230 molecules are present in the adnexal BMs. 
This finding supports the hypothesis that loss of immune 
tolerance against BP180 could originate from the sweat 
glands or SGDs, where certain drugs or other haptens 
excreted by sweat would be able to bind to BP180 and 
induce autoimmune reaction.
A previous report (6) and our clinical experience show 
that some patients with BP can display only positive 
linear fluorescence along the BM of SGDs without the 
diagnostic linear staining of the epidermal BM; however, 
it is not yet understood whether isolated SGD positivity 
is an early diagnostic predictor of BP and whether it can 
be a reliable diagnostic sign for BP.
In conclusion, linear deposits of IgG along the BM of 
SGDs are highly sensitive for BP in each level of dermis; 
however, only strong fluorescence has acceptable spe­
cificity. SGD positivity in the upper dermis was found 
to be more BP-specific than in the lower dermis. Thus, 
evaluation of the localization and the intensity of adnexal 
IgG fluorescence is important, and SGD immunoreac­
tivity may have diagnostic relevance in BP. However, 
further controlled studies are necessary to recommend 
SGD fluorescence as the basis for diagnosis of BP, even 
with strong signal intensity. 
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